A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

ClinicalTrials.gov ID: NCT07606066

Public ClinicalTrials.gov record NCT07606066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT07606066
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: AstraZeneca; Industry
Enrollment: 2,150 participants

Conditions and interventions

Conditions

Type 2 Diabetes

Interventions

Procedure: assessment Other

Other

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 5, 2026
Primary completion: Mar 30, 2027
Completion: Mar 30, 2027
Last update posted: Jul 6, 2026

2026 – 2027

United States locations

U.S. sites: 9
U.S. states: 8
U.S. cities: 9

Facility	City	State	ZIP	Site status
Research Site	Little Rock	Arkansas	72205	Not yet recruiting
Research Site	Lincoln	California	95648	Recruiting
Research Site	Lake City	Florida	32055	Not yet recruiting
Research Site	Ocoee	Florida	34761	Recruiting
Research Site	Decatur	Georgia	30030	Recruiting
Research Site	El Dorado	Kansas	67042	Not yet recruiting
Research Site	Potomac	Maryland	20854	Recruiting
Research Site	Gaffney	South Carolina	29340	Active, not recruiting
Research Site	Renton	Washington	98057	Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07606066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jul 6, 2026 · Synced Jul 23, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07606066 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →